Affordable_access Target a healthcare facilities segment in emerging markets with CervAstra and Astra AI tools to expand access to cervical cancer screening, leveraging their mission to democratize quality care and the current emphasis on affordable, quick point-of-care solutions.

AI_platform Position Astra as a modular AI platform capable of expanding into additional critical illnesses beyond cervical cancer, offering scalable detection tools to hospitals and clinics looking to upgrade diagnostic capabilities.

Collaborative_partnerships Leverage past IIT Mandi collaboration and academic ties to unlock co-development or grant-funded pilots, accelerating adoption in tertiary centers and primary health networks that require validated AI-assisted screening.

Low_cost_proposition Emphasize cost-efficient, point-of-care screening as a differentiator for clinics with tight budgets, highlighting rapid deployment, minimal infrastructure requirements, and the potential for bundled service/support models.

Growth_potential Highlight incremental revenue opportunities from expanding the CervAstra portfolio, cross-selling into other screening and computational pathology tools, and leveraging AWS, cloud and database capabilities to offer scalable, managed solution packages.